DuPont Reports 2Q 2014 Operating EPS of $1.17

WILMINGTON, Del., July 22, 2014 – DuPont (NYSE: DD), a science company that brings world-class, innovative products, materials and services to the global marketplace, today announced second quarter 2014 operating earnings of $1.17 per share compared to $1.28 per share in the prior year.  GAAP1 earnings per share were $1.15 versus $1.10 last year.  Consolidated sales were $9.7 billion, 1 percent below last year, reflecting portfolio changes, as price, volume and currency were in line with the prior year period.

“While lower Agriculture earnings impacted our results this quarter, we continue to see strong science-driven growth in this segment over the long term.  We are steadily advancing DuPont’s strategy to build and strengthen world-leading positions in agriculture and nutrition, bio-based industrials and advanced materials,” said DuPont Chair and CEO Ellen Kullman.  “As we move ahead with our Performance Chemicals separation, we also have launched the initial stage of a broad initiative to reset our operating model.  This work is already gaining traction and will continue to expand, positioning DuPont to drive greater growth and value with a simplified, streamlined support structure and a smaller cost base - consistent with the purpose, strategy and needs of the DuPont company, post-separation.”

1Generally Accepted Accounting Principles (GAAP)

For additional information about DuPont and its commitment to inclusive innovation, please visit http://www.dupont.com.

Additional information is available on the DuPont Investor Center website at http://www.investors.dupont.com

Forward-Looking Statements: This news release contains forward-looking statements which may be identified by their use of words like “plans,” “expects,” “will,” "believes," “intends,” “estimates,” “anticipates” or other words of similar meaning. All statements that address expectations or projections about the future, including statements about the company’s growth strategy, product development, regulatory approval, market position, anticipated benefi ts of acquisitions, outcome of contingencies, such as litigation and environmental matters, expenditures and financial results, are forward-looking statements. Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond the company’s control. Some of the important factors that could cause the company’s actual results to differ materially from those projected in any such forward-looking statements are: fluctuations in energy and raw material prices; failure to develop and market new products and optimally manage product life cycles; significant litigation and environmental matters; failure to appropriately manage process safety and product stewardship issues; changes in laws and regulations or political conditions; global economic and capital markets conditions, such as inflation, interest and currency exchange rates; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, weather events and natural disasters; ability to protect and enforce the company's intellectual property rights; successful integration of acquired businesses and separation of underperforming or non-strategic assets or businesses and successful completion of the proposed spinoff of the Performance Chemicals segment including ability to fully realize the expected benefits of the proposed spinoff.

The company undertakes no duty to update any forward-looking statements as a result of future developments or new information.